Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Hormone Refractory Prostate Cancer
NCT00077402Phase 2Completed
- Sponsor
- Cancer Therapeutics Research Group
- Start
- Nov 2003
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of fenretinide in prostate cancer (PCa), sponsored by Cancer Therapeutics Research Group. Started Nov 2003; status: completed.
02
Drugs
fenretinide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00077402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077402.